The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.62
Bid: 41.66
Ask: 41.72
Change: -0.02 (-0.05%)
Spread: 0.06 (0.144%)
Open: 41.60
High: 42.34
Low: 41.38
Prev. Close: 41.64
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Interim CEO and director

3 Oct 2016 07:00

RNS Number : 4489L
Assura PLC
03 October 2016
 

Assura plc 

 

Appointment of Jonathan Murphy as Interim CEO and Andrew Darke as Property Director to the Board

 

The search process to appoint a new Chief Executive Officer for Assura is ongoing. While the process continues, Jonathan Murphy, currently the Finance Director, has been appointed Interim CEO to lead the business through this time as well as continuing with his responsibilities as Finance Director. Andrew Darke, Property Director, has also been appointed to the board, retaining responsibility for the property operations and developments. Simon Laffin, who has been Executive Chairman since March, will revert to his non-executive role.

 

Simon Laffin commented:

 

"We are focused on appointing the right person as CEO. I am delighted that Jonathan Murphy has agreed to take on the role on an interim basis and that Andrew Darke is joining the board. These appointments reflect the great work that they have both done over this transitional period."

 

Jonathan Murphy said:

 

"Assura continues to trade well with further strong growth as shown by today's trading update. I look forward to working with Andrew Darke on the board to ensure our continued success."

 

There is no information required to be disclosed pursuant to Listing Rule 9.6.13R in respect of Andrew Darke.

 

 

 - Ends-

 

For more information, please contact:

 

 

Assura plc

 

Tel: 01925 420660

Simon Laffin

Jonathan Murphy

 

 

Finsbury

 

Tel: 0207 251 3801

Gordon Simpson

 

 

Notes to Editors

 

On 4 March this year, Assura announced that Simon Laffin was becoming Executive Chairman to cover the absence of Graham Roberts, the CEO. This was further updated on 14 June, when it was announced that Graham was stepping down as CEO, and that Simon would remain as Executive Chairman whilst a process to appoint a new CEO was in process. On 4 July, the company announced that Graham had sadly passed away. 

 

Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington,

works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2016, Assura's property portfolio was valued at £1,111million.

 

 Further information is available at www.assuraplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAFEFEEPKFAF
Date   Source Headline
27th Jun 20234:18 pmRNSHolding(s) in Company
27th Jun 20238:33 amRNSHolding(s) in Company
15th Jun 20237:31 amRNSScrip Calculation Price
14th Jun 20239:01 amRNSHolding(s) in Company
12th Jun 20234:23 pmRNSDirector/PDMR Shareholding
5th Jun 202310:54 amRNSDirector/PDMR Shareholding
2nd Jun 20237:00 amRNSAnnual Report & Notice of AGM
1st Jun 20237:00 amRNSNotice of Dividend
23rd May 20237:00 amRNSAssura Full Year Results 2023
12th May 20237:00 amRNSNotice of Results
10th May 202310:53 amRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
25th Apr 20234:12 pmRNSHolding(s) in Company
17th Apr 20234:06 pmRNSDirector/PDMR Shareholding
11th Apr 20238:43 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSScrip Dividend Declaration
16th Mar 202310:13 amRNSScrip Calculation Price
13th Mar 20237:00 amRNSMSCI ESG rating upgrade and energy reduction pilot
7th Mar 202310:43 amRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSNotice of Dividend
15th Feb 20231:51 pmRNSHolding(s) in Company
7th Feb 20239:57 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
26th Jan 20231:48 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSTrading Update
13th Jan 20232:55 pmRNSDirector/PDMR Shareholding
9th Jan 202311:33 amRNSDirector/PDMR Shareholding
9th Jan 20237:00 amRNSScrip Dividend Declaration
15th Dec 20229:07 amRNSScrip calculation price
6th Dec 20229:03 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSDividend Declaration
22nd Nov 20227:00 amRNSDelivering continued growth
15th Nov 202212:15 pmRNSHolding(s) in Company
8th Nov 20229:02 amRNSDirector/PDMR Shareholding
1st Nov 20222:02 pmRNSHolding(s) in Company
31st Oct 20228:43 amRNSTotal Voting Rights
17th Oct 202212:10 pmRNSDirector/PDMR Shareholding
11th Oct 20221:49 pmRNSHolding(s) in Company
10th Oct 20227:00 amRNSScrip Dividend Declaration
7th Oct 202210:14 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSTrading Update
15th Sep 20227:00 amRNSScrip calculation price
14th Sep 20225:37 pmRNSDirector/PDMR Shareholding
13th Sep 20224:28 pmRNSHolding(s) in Company
1st Sep 20227:00 amRNSDividend Declaration
8th Aug 202212:51 pmRNSDirector/PDMR Shareholding
29th Jul 20229:27 amRNSTotal Voting Rights
18th Jul 20222:53 pmRNSDirector/PDMR Shareholding
13th Jul 20225:17 pmRNSExercise of Nil Cost Options under PSP
13th Jul 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.